An investigation on behalf of investors in Alphatec Holdings, Inc. (NASDAQ: ATEC) shares over potential wrongdoing at Alphatec Holdings was announced.
San Diego, CA -- (SBWIRE) -- 08/30/2018 -- An investigation was announced concerning possible breaches of fiduciary duties by certain directors at Alphatec Holdings.
Investors who purchased shares of Alphatec Holdings, Inc. (NASDAQ: ATEC) have certain options and should contact the Shareholders Foundation at email@example.com or call +1(858) 779 - 1554.
The investigation by a law firm concerns whether certain Alphatec Holdings directors breached their fiduciary duties and caused damage to the company and its shareholders.
Carlsbad, CA based Alphatec Holdings, Inc., a medical technology company, focuses on the design, development, and promotion of products for the surgical treatment of spine disorders. Alphatec Holdings, Inc. reported that its annual Total Revenue rose from $120.24 million in 2016 to $101.73 million in 2017 and that its Net Loss declined from $29.92 million in 2016 to $2.29 million in 2017.
Shares of Alphatec Holdings, Inc. (NASDAQ: ATEC) closed on August 29, 2018, at $3.63 per share.
Those who purchased shares of Alphatec Holdings, Inc. (NASDAQ: ATEC), have certain options and should contact the Shareholders Foundation.
Shareholders Foundation, Inc.
3111 Camino Del Rio North - Suite 423
92108 San Diego
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, , which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigation, and/or settlements are not filed/reached and/or related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.
For more information on this press release visit:
Media Relations Contact
Email: Click to Email Michael Daniels